Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Glad to see Bertner earning her money and giving sound investor relation advice.
I guess no news today.
I hope you are right. This is depressing.
I guess we'll find out.
We still expecting news this week?
You know, as owners of the company.
Maybe if we all email John H with our concerns, they'll start to "hear" us.
It kills me that we are not on a level playing field.
It sounds like they are manipulating the system and because of this manipulation, can control the PPS. I would think that any manipulation to control price is illegal.
How is this manipulation not illegal?
I had today or tomorrow as the likely days.
Next week should be interesting.
No, I've bought a bunch as well. Happy to see more buying. Just wish the price would start to creep up.
Nice buys at the end of the day.
If the DMC recommends stopping the trial indicating that the primary endpoint has been meet and not for lack of efficacy, any predictions on price movement?
I'm still having a hard time understanding why this thing has seen a little run up to feedback from the DMC especially as they come so close to meeting the primary endpoint in the previous Phase 3 trial.
Why all the sells this close to feedback from DMC? Should we worry?
There's that small sell again at close. Must have nothing better to do.
Who is the person that keeps selling at the close? I should start buying at the close.
Ok. Yes thanks. I thought you were stating that there was recent insider buying.
No problem. Do you have info on insiders buying?
The DMC.
We should hear from the DC in early September regarding Phase 3. DC can tell SNWV to stop enrollment, which would be an indication that the endpoint gas been met or to continue enrollment to 130 patients because results are good but need more data. Can also say to stop the trial because results are bad but IMO not likely because of the good results from previous Phase 3.
What's up with all the sells at the open?
Yep. I would like to see the price start to move North a little. About a month away from feedback from the DMC.
I thought there was a call or update some time next week.
When is the conference call and did they send out call-in information. Thanks.
Sounds promising. I bought more shares.
I hope so. The DMC is reviewing the data from the first 90 patients. It may be too early to get feedback from the review.
The 90 patients that you are talking about was the minimum enrollment for the trial. If, after the first 90 patients are evaluated, the results look promising but the primary endpoint has not been met, they can continue the trial with additional patients. I think the next review if necessary, is after an additional 40 patients. Therefore, they have multiple opportunities to meet the primary endpoint. They were so close in meeting the primary endpoint in the original Phase 3 trial and with a better trial design in the current trial, IMO, they have a high probability of meeting the primary endpoint in this trial.
Tell me about. I can't believe people are selling this close to an announcement regarding Ph III. The 12 week follow up period ends 7/30 so we should hear from the DMC in about a month.
I know. I've been accumulating for over a year so starting to get a little impatient.
Nice buys today. The presentation was positive. I wish the stock price would reflect that.
Plus, they barely missed the endpoint of the previous Phase III trial. In response, this trial was designed for success with that in mind. Very frustrating.
This stock has been mind boggling for months. I can't believe people are selling this close to possible stoppage of Phase III trial because endpoint may be reached.
Back in 2011, the price ran up to the $5-$6 range in anticipation of the Phase 3 results. This time, in my opinion, there is a greater likelihood of success in Phase 3 based on the trial design, etc. Therefore, I would think that this should run up to around the same dollar price, IMO. Just surprised we haven't seen any movement yet.
While I understand that they may not have experience on the corporate side in that they are coming from academia, it is the job of investor relations to educate them. Therefore, I see this as a failure on the part of Beverly. Six months, no news, she has time to educate. What is she getting paid for?
Well then, someone should tell them they are not in academia and a publicly traded company needs shareholders and the way to attract shareholders is to increase value. I'm happy that they are concentrating on development but in the positions they are in now, they also have to consider the shareholders.
Will anything move this price up? All buys yesterday at .50.
Great. Thanks. Just debating on whether to sell some shares in case of a drop to buy back more at a lower price. Very hesitant because I think this will start to run up but did not know how much to factor in the Ukraine crisis.